OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -39.3% | 11,881 | 0.0% | 0.00% | – |
| Q2 2023 | $61 | +7.0% | 11,881 | +10.6% | 0.00% | – |
| Q1 2023 | $57 | +62.9% | 10,744 | -13.1% | 0.00% | – |
| Q4 2022 | $35 | -99.9% | 12,360 | 0.0% | 0.00% | – |
| Q3 2022 | $51,000 | +4.1% | 12,360 | +1.6% | 0.00% | – |
| Q2 2022 | $49,000 | -21.0% | 12,164 | -2.8% | 0.00% | – |
| Q1 2022 | $62,000 | -67.0% | 12,519 | -53.7% | 0.00% | -100.0% |
| Q4 2021 | $188,000 | +36.2% | 27,064 | +96.3% | 0.00% | 0.0% |
| Q3 2021 | $138,000 | -32.7% | 13,785 | -4.8% | 0.00% | -50.0% |
| Q2 2021 | $205,000 | +21.3% | 14,475 | +40.9% | 0.00% | -66.7% |
| Q1 2021 | $169,000 | -23.5% | 10,272 | -3.7% | 0.01% | -25.0% |
| Q4 2020 | $221,000 | – | 10,662 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |